

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to pheromone (GO:0019236) | 8.89422459 |
| 2 | dopamine biosynthetic process (GO:0042416) | 8.81781653 |
| 3 | dopamine transport (GO:0015872) | 8.68046484 |
| 4 | regulation of catecholamine metabolic process (GO:0042069) | 8.27892910 |
| 5 | regulation of dopamine metabolic process (GO:0042053) | 8.27892910 |
| 6 | tachykinin receptor signaling pathway (GO:0007217) | 7.30787020 |
| 7 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 7.06362956 |
| 8 | growth hormone secretion (GO:0030252) | 6.96437195 |
| 9 | alkaloid metabolic process (GO:0009820) | 6.83865429 |
| 10 | mating behavior (GO:0007617) | 6.66846434 |
| 11 | positive regulation of growth hormone secretion (GO:0060124) | 6.57739794 |
| 12 | catecholamine transport (GO:0051937) | 6.36460962 |
| 13 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 6.34113420 |
| 14 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 6.09486954 |
| 15 | sequestering of actin monomers (GO:0042989) | 6.06694386 |
| 16 | behavioral response to nicotine (GO:0035095) | 5.86977392 |
| 17 | hyperosmotic salinity response (GO:0042538) | 5.58103325 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 5.34745051 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.28009271 |
| 20 | catechol-containing compound biosynthetic process (GO:0009713) | 5.17486265 |
| 21 | catecholamine biosynthetic process (GO:0042423) | 5.17486265 |
| 22 | response to cocaine (GO:0042220) | 5.15423854 |
| 23 | regulation of uterine smooth muscle contraction (GO:0070472) | 4.95639339 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.89368202 |
| 25 | response to insecticide (GO:0017085) | 4.87374402 |
| 26 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.86497580 |
| 27 | synaptic transmission, dopaminergic (GO:0001963) | 4.80904159 |
| 28 | glutamate secretion (GO:0014047) | 4.79404767 |
| 29 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.78508205 |
| 30 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.78187558 |
| 31 | regulation of growth hormone secretion (GO:0060123) | 4.69698373 |
| 32 | negative regulation of leukocyte chemotaxis (GO:0002689) | 4.69540583 |
| 33 | neurotransmitter biosynthetic process (GO:0042136) | 4.64904641 |
| 34 | phenol-containing compound catabolic process (GO:0019336) | 4.58400455 |
| 35 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.58214427 |
| 36 | prepulse inhibition (GO:0060134) | 4.55107131 |
| 37 | synaptic transmission, cholinergic (GO:0007271) | 4.54869901 |
| 38 | cellular response to nicotine (GO:0071316) | 4.54333939 |
| 39 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.50977358 |
| 40 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.42635254 |
| 41 | detection of light stimulus involved in visual perception (GO:0050908) | 4.42635254 |
| 42 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.40822111 |
| 43 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 4.39271576 |
| 44 | regulation of feeding behavior (GO:0060259) | 4.38114217 |
| 45 | microtubule depolymerization (GO:0007019) | 4.30870247 |
| 46 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 4.28006916 |
| 47 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.25092842 |
| 48 | axon extension involved in axon guidance (GO:0048846) | 4.25092842 |
| 49 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.23807344 |
| 50 | dopamine metabolic process (GO:0042417) | 4.23035502 |
| 51 | membrane hyperpolarization (GO:0060081) | 4.13562740 |
| 52 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 4.08841974 |
| 53 | determination of adult lifespan (GO:0008340) | 4.08190118 |
| 54 | chaperone-mediated protein complex assembly (GO:0051131) | 4.05522770 |
| 55 | protein complex biogenesis (GO:0070271) | 4.04054373 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.96775459 |
| 57 | synaptic vesicle maturation (GO:0016188) | 3.93439064 |
| 58 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 3.90240131 |
| 59 | synaptic vesicle endocytosis (GO:0048488) | 3.89971461 |
| 60 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.88606986 |
| 61 | monoamine transport (GO:0015844) | 3.85923263 |
| 62 | innervation (GO:0060384) | 3.85180745 |
| 63 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.84369133 |
| 64 | NADH dehydrogenase complex assembly (GO:0010257) | 3.84369133 |
| 65 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.84369133 |
| 66 | neuron remodeling (GO:0016322) | 3.82343340 |
| 67 | ATP synthesis coupled proton transport (GO:0015986) | 3.80232731 |
| 68 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.80232731 |
| 69 | behavioral response to cocaine (GO:0048148) | 3.77844383 |
| 70 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.77107454 |
| 71 | neurotransmitter catabolic process (GO:0042135) | 3.73704719 |
| 72 | synaptic vesicle transport (GO:0048489) | 3.72586887 |
| 73 | establishment of synaptic vesicle localization (GO:0097480) | 3.72586887 |
| 74 | protein localization to synapse (GO:0035418) | 3.69286892 |
| 75 | cellular potassium ion homeostasis (GO:0030007) | 3.68266132 |
| 76 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.68103587 |
| 77 | tyrosine metabolic process (GO:0006570) | 3.62420496 |
| 78 | neuromuscular process controlling posture (GO:0050884) | 3.61504823 |
| 79 | negative regulation of axon guidance (GO:1902668) | 3.59984894 |
| 80 | kynurenine metabolic process (GO:0070189) | 3.58908954 |
| 81 | neurotransmitter metabolic process (GO:0042133) | 3.57818708 |
| 82 | positive regulation of amino acid transport (GO:0051957) | 3.55394397 |
| 83 | toxin metabolic process (GO:0009404) | 3.52039481 |
| 84 | negative regulation of microtubule polymerization (GO:0031115) | 3.48001417 |
| 85 | viral transcription (GO:0019083) | 3.47815799 |
| 86 | synaptic transmission, glutamatergic (GO:0035249) | 3.47155681 |
| 87 | nonmotile primary cilium assembly (GO:0035058) | 3.46917850 |
| 88 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.46365569 |
| 89 | regulation of neurotransmitter levels (GO:0001505) | 3.44326791 |
| 90 | translational termination (GO:0006415) | 3.41426190 |
| 91 | neurotransmitter secretion (GO:0007269) | 3.40811363 |
| 92 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.37010327 |
| 93 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.37010327 |
| 94 | indole-containing compound catabolic process (GO:0042436) | 3.35290553 |
| 95 | indolalkylamine catabolic process (GO:0046218) | 3.35290553 |
| 96 | tryptophan catabolic process (GO:0006569) | 3.35290553 |
| 97 | DNA deamination (GO:0045006) | 3.33765350 |
| 98 | negative regulation of neurotransmitter transport (GO:0051589) | 3.33086813 |
| 99 | positive regulation of cell size (GO:0045793) | 3.29305697 |
| 100 | neurotransmitter transport (GO:0006836) | 3.28666979 |
| 101 | photoreceptor cell development (GO:0042461) | 3.28629314 |
| 102 | cullin deneddylation (GO:0010388) | 3.27022162 |
| 103 | retinal ganglion cell axon guidance (GO:0031290) | 3.26104711 |
| 104 | regulation of synaptic vesicle transport (GO:1902803) | 3.23161732 |
| 105 | retinal rod cell development (GO:0046548) | 3.22097728 |
| 106 | cAMP-mediated signaling (GO:0019933) | 3.21748063 |
| 107 | protein deneddylation (GO:0000338) | 3.20383844 |
| 108 | maturation of SSU-rRNA (GO:0030490) | 3.19287622 |
| 109 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.17879729 |
| 110 | neuron maturation (GO:0042551) | 3.17712918 |
| 111 | eye photoreceptor cell development (GO:0042462) | 3.17078400 |
| 112 | kidney morphogenesis (GO:0060993) | 3.17019185 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.16553233 |
| 114 | transmission of nerve impulse (GO:0019226) | 3.15141023 |
| 115 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.13597929 |
| 116 | vocalization behavior (GO:0071625) | 3.13154796 |
| 117 | positive regulation of microtubule polymerization (GO:0031116) | 3.11691281 |
| 118 | phenol-containing compound biosynthetic process (GO:0046189) | 3.11309253 |
| 119 | response to amphetamine (GO:0001975) | 3.07643202 |
| 120 | synapse assembly (GO:0007416) | 3.05201072 |
| 121 | positive regulation of heart rate (GO:0010460) | 3.04186265 |
| 122 | detection of temperature stimulus (GO:0016048) | 3.04158129 |
| 123 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03626899 |
| 124 | indolalkylamine metabolic process (GO:0006586) | 3.02048493 |
| 125 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.01736204 |
| 126 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.01736204 |
| 127 | microtubule polymerization or depolymerization (GO:0031109) | 2.99903730 |
| 128 | * regulation of dopamine secretion (GO:0014059) | 2.99809499 |
| 129 | response to auditory stimulus (GO:0010996) | 2.98834081 |
| 130 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.97557924 |
| 131 | ribosomal small subunit assembly (GO:0000028) | 2.97311855 |
| 132 | regulation of postsynaptic membrane potential (GO:0060078) | 2.96044758 |
| 133 | regulation of mononuclear cell migration (GO:0071675) | 2.94370484 |
| 134 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.94040422 |
| 135 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.94040422 |
| 136 | neuron fate determination (GO:0048664) | 2.93206790 |
| 137 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.92542402 |
| 138 | response to morphine (GO:0043278) | 2.92221505 |
| 139 | regulation of vesicle fusion (GO:0031338) | 2.91960315 |
| 140 | urinary tract smooth muscle contraction (GO:0014848) | 2.91877179 |
| 141 | auditory behavior (GO:0031223) | 2.90322312 |
| 142 | benzene-containing compound metabolic process (GO:0042537) | 2.90315780 |
| 143 | tryptophan metabolic process (GO:0006568) | 2.90277292 |
| 144 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.90063091 |
| 145 | negative regulation of vascular permeability (GO:0043116) | 2.89732473 |
| 146 | multicellular organismal aging (GO:0010259) | 2.89573944 |
| 147 | neuronal action potential (GO:0019228) | 2.89508927 |
| 148 | response to ammonium ion (GO:0060359) | 2.89235818 |
| 149 | establishment of vesicle localization (GO:0051650) | 2.89015164 |
| 150 | behavioral response to pain (GO:0048266) | 2.88464202 |
| 151 | response to histamine (GO:0034776) | 2.88183597 |
| 152 | protein import into peroxisome matrix (GO:0016558) | 2.87697869 |
| 153 | retinal cone cell development (GO:0046549) | 2.87003083 |
| 154 | respiratory electron transport chain (GO:0022904) | 2.86738471 |
| 155 | electron transport chain (GO:0022900) | 2.85895332 |
| 156 | regulation of axon guidance (GO:1902667) | 2.84447107 |
| 157 | regulation of microtubule polymerization (GO:0031113) | 2.84093306 |
| 158 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.83040961 |
| 159 | cotranslational protein targeting to membrane (GO:0006613) | 2.82535574 |
| 160 | cellular protein complex disassembly (GO:0043624) | 2.81851277 |
| 161 | rRNA catabolic process (GO:0016075) | 2.79540415 |
| 162 | protein targeting to ER (GO:0045047) | 2.73795683 |
| 163 | positive regulation of multicellular organism growth (GO:0040018) | 2.73308660 |
| 164 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.72908515 |
| 165 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.72451591 |
| 166 | cell differentiation in spinal cord (GO:0021515) | 2.69776825 |
| 167 | translational elongation (GO:0006414) | 2.68908459 |
| 168 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.67786694 |
| 169 | cellular response to interferon-beta (GO:0035458) | 2.67269841 |
| 170 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.65987541 |
| 171 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.64586820 |
| 172 | bile acid and bile salt transport (GO:0015721) | 2.62384743 |
| 173 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.61359125 |
| 174 | limb development (GO:0060173) | 2.60779584 |
| 175 | appendage development (GO:0048736) | 2.60779584 |
| 176 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.60425454 |
| 177 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.59844600 |
| 178 | positive regulation of gastrulation (GO:2000543) | 2.58124548 |
| 179 | respiratory chain complex IV assembly (GO:0008535) | 2.57966566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 4.76439784 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.17473026 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.01378404 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.86688341 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.30493748 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.05952539 |
| 7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.93912556 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.82564716 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.65971906 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.60389958 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58564867 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54874244 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.50887541 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.48390475 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.47170605 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.40595551 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.40595551 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.39441966 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36461580 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.35901020 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.34502162 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.29760200 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26755282 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.21012253 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20979309 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.19254523 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.15699743 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.12450073 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09680872 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.07694853 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.03842284 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02495904 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95897695 |
| 34 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.92666587 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91472572 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.91078006 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90465228 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89355520 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.87977422 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.86151796 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.81127025 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.80384410 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76427335 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69378270 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68736595 |
| 46 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.67414830 |
| 47 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.65369675 |
| 48 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61631630 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60999469 |
| 50 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.60539050 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55345954 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54700582 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47871337 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47703811 |
| 55 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.44880487 |
| 56 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.43038835 |
| 57 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.42806306 |
| 58 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.42806306 |
| 59 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.42444832 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.42246401 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41959013 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41238516 |
| 63 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.40179139 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39628772 |
| 65 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39545612 |
| 66 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.36598177 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34648917 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34553418 |
| 69 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.33944724 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33944724 |
| 71 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31732619 |
| 72 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31097105 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30712634 |
| 74 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28696810 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28506009 |
| 76 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.27820835 |
| 77 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27371766 |
| 78 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27371766 |
| 79 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26885224 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25815921 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25782398 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25697242 |
| 83 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25675451 |
| 84 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25356915 |
| 85 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24282442 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22966618 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.20712393 |
| 88 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19239912 |
| 89 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16111263 |
| 90 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14753782 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13530768 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13377118 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12063179 |
| 94 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.10651482 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09667432 |
| 96 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.09364205 |
| 97 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07790654 |
| 98 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04380411 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04117463 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03709454 |
| 101 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02804052 |
| 102 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.00394164 |
| 103 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00080490 |
| 104 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99531666 |
| 105 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99221848 |
| 106 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99221848 |
| 107 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98751835 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98466736 |
| 109 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97719547 |
| 110 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97389658 |
| 111 | ERA_21632823_ChIP-Seq_H3396_Human | 0.97040428 |
| 112 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96494057 |
| 113 | AR_19668381_ChIP-Seq_PC3_Human | 0.96450548 |
| 114 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.95353067 |
| 115 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.95302350 |
| 116 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.95248726 |
| 117 | JUN_21703547_ChIP-Seq_K562_Human | 0.95224963 |
| 118 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95105086 |
| 119 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94480754 |
| 120 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93673613 |
| 121 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.92620448 |
| 122 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92589194 |
| 123 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92578075 |
| 124 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.92480949 |
| 125 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91880675 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91778282 |
| 127 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.91597784 |
| 128 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.91146186 |
| 129 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90701931 |
| 130 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90680573 |
| 131 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90555163 |
| 132 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90267630 |
| 133 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89974012 |
| 134 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.89086560 |
| 135 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88902315 |
| 136 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.88510428 |
| 137 | EWS_26573619_Chip-Seq_HEK293_Human | 0.88266652 |
| 138 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88171729 |
| 139 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.88013413 |
| 140 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86480359 |
| 141 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86359414 |
| 142 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80941090 |
| 143 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.78692419 |
| 144 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.77397781 |
| 145 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.77351075 |
| 146 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.77004987 |
| 147 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.76908035 |
| 148 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.76608016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.35210822 |
| 2 | MP0002735_abnormal_chemical_nociception | 4.46062221 |
| 3 | MP0001905_abnormal_dopamine_level | 4.13467486 |
| 4 | MP0006276_abnormal_autonomic_nervous | 3.94326884 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.89358087 |
| 6 | MP0002736_abnormal_nociception_after | 3.54073086 |
| 7 | MP0001529_abnormal_vocalization | 3.17964449 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 3.16040553 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 3.08502508 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 3.03549901 |
| 11 | MP0005423_abnormal_somatic_nervous | 3.03157604 |
| 12 | MP0002102_abnormal_ear_morphology | 2.98042565 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.93647789 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.86902441 |
| 15 | MP0002653_abnormal_ependyma_morphology | 2.70990610 |
| 16 | MP0002733_abnormal_thermal_nociception | 2.60376178 |
| 17 | MP0000566_synostosis | 2.56454173 |
| 18 | MP0009046_muscle_twitch | 2.53447711 |
| 19 | MP0003283_abnormal_digestive_organ | 2.44403134 |
| 20 | MP0002272_abnormal_nervous_system | 2.42402468 |
| 21 | MP0002064_seizures | 2.37655612 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.30981648 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.28963922 |
| 24 | MP0002909_abnormal_adrenal_gland | 2.28541073 |
| 25 | MP0001970_abnormal_pain_threshold | 2.26740028 |
| 26 | MP0004270_analgesia | 2.21509880 |
| 27 | MP0002063_abnormal_learning/memory/cond | 2.20861089 |
| 28 | MP0002090_abnormal_vision | 2.18687987 |
| 29 | MP0009745_abnormal_behavioral_response | 2.14744595 |
| 30 | MP0001486_abnormal_startle_reflex | 2.14227230 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 2.12002603 |
| 32 | MP0003959_abnormal_lean_body | 2.11412955 |
| 33 | MP0002822_catalepsy | 2.04545239 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 2.00986759 |
| 35 | MP0002067_abnormal_sensory_capabilities | 1.96693775 |
| 36 | MP0003136_yellow_coat_color | 1.93439987 |
| 37 | MP0006072_abnormal_retinal_apoptosis | 1.92386301 |
| 38 | MP0004924_abnormal_behavior | 1.91839752 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.91839752 |
| 40 | MP0006292_abnormal_olfactory_placode | 1.85520935 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76704993 |
| 42 | MP0005253_abnormal_eye_physiology | 1.76363225 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.71791376 |
| 44 | MP0003011_delayed_dark_adaptation | 1.70454635 |
| 45 | MP0002184_abnormal_innervation | 1.70266358 |
| 46 | MP0004858_abnormal_nervous_system | 1.64765240 |
| 47 | MP0008872_abnormal_physiological_respon | 1.63995915 |
| 48 | MP0000534_abnormal_ureter_morphology | 1.61515071 |
| 49 | MP0000026_abnormal_inner_ear | 1.59975677 |
| 50 | MP0001501_abnormal_sleep_pattern | 1.58966172 |
| 51 | MP0003122_maternal_imprinting | 1.55631006 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.54079972 |
| 53 | MP0005671_abnormal_response_to | 1.53955296 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.47860547 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.47705154 |
| 56 | MP0004043_abnormal_pH_regulation | 1.47172692 |
| 57 | MP0010030_abnormal_orbit_morphology | 1.46851622 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 1.45255954 |
| 59 | MP0003878_abnormal_ear_physiology | 1.42302296 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 1.42302296 |
| 61 | MP0005535_abnormal_body_temperature | 1.41765875 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.34916208 |
| 63 | MP0005248_abnormal_Harderian_gland | 1.33629529 |
| 64 | MP0002229_neurodegeneration | 1.29735540 |
| 65 | MP0004811_abnormal_neuron_physiology | 1.29520035 |
| 66 | MP0001984_abnormal_olfaction | 1.29227152 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.28743487 |
| 68 | MP0001188_hyperpigmentation | 1.27575852 |
| 69 | MP0002332_abnormal_exercise_endurance | 1.27108806 |
| 70 | MP0003868_abnormal_feces_composition | 1.24209412 |
| 71 | MP0002938_white_spotting | 1.23657737 |
| 72 | MP0001881_abnormal_mammary_gland | 1.21303195 |
| 73 | MP0000569_abnormal_digit_pigmentation | 1.18960057 |
| 74 | MP0005409_darkened_coat_color | 1.16966426 |
| 75 | MP0002638_abnormal_pupillary_reflex | 1.16050851 |
| 76 | MP0002066_abnormal_motor_capabilities/c | 1.14789408 |
| 77 | MP0003329_amyloid_beta_deposits | 1.14727521 |
| 78 | MP0004142_abnormal_muscle_tone | 1.14493122 |
| 79 | MP0005195_abnormal_posterior_eye | 1.14316035 |
| 80 | MP0000685_abnormal_immune_system | 1.12752456 |
| 81 | MP0004133_heterotaxia | 1.12494290 |
| 82 | MP0000955_abnormal_spinal_cord | 1.11264006 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 1.10963168 |
| 84 | MP0010386_abnormal_urinary_bladder | 1.09788662 |
| 85 | MP0001664_abnormal_digestion | 1.07824696 |
| 86 | MP0001663_abnormal_digestive_system | 1.07334302 |
| 87 | MP0005387_immune_system_phenotype | 1.05539254 |
| 88 | MP0001790_abnormal_immune_system | 1.05539254 |
| 89 | MP0001873_stomach_inflammation | 1.03616075 |
| 90 | MP0000778_abnormal_nervous_system | 1.02786111 |
| 91 | MP0002752_abnormal_somatic_nervous | 1.02466025 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 1.01103869 |
| 93 | MP0003950_abnormal_plasma_membrane | 1.01012255 |
| 94 | MP0000639_abnormal_adrenal_gland | 1.00559811 |
| 95 | MP0003938_abnormal_ear_development | 0.97958137 |
| 96 | MP0000631_abnormal_neuroendocrine_gland | 0.97317581 |
| 97 | MP0001800_abnormal_humoral_immune | 0.97151203 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.96718365 |
| 99 | MP0001293_anophthalmia | 0.95242760 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.94377864 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.94302770 |
| 102 | MP0002751_abnormal_autonomic_nervous | 0.92961134 |
| 103 | MP0005499_abnormal_olfactory_system | 0.91898538 |
| 104 | MP0005394_taste/olfaction_phenotype | 0.91898538 |
| 105 | MP0000751_myopathy | 0.91338666 |
| 106 | MP0000579_abnormal_nail_morphology | 0.89861998 |
| 107 | MP0004742_abnormal_vestibular_system | 0.86889615 |
| 108 | MP0003631_nervous_system_phenotype | 0.85226255 |
| 109 | MP0001346_abnormal_lacrimal_gland | 0.83977606 |
| 110 | MP0003632_abnormal_nervous_system | 0.83545582 |
| 111 | MP0001919_abnormal_reproductive_system | 0.82214405 |
| 112 | MP0008874_decreased_physiological_sensi | 0.80441019 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.80122366 |
| 114 | MP0000383_abnormal_hair_follicle | 0.79845179 |
| 115 | MP0003633_abnormal_nervous_system | 0.79771326 |
| 116 | MP0005187_abnormal_penis_morphology | 0.76426528 |
| 117 | MP0008569_lethality_at_weaning | 0.75895941 |
| 118 | MP0003942_abnormal_urinary_system | 0.75269497 |
| 119 | MP0003634_abnormal_glial_cell | 0.74672159 |
| 120 | MP0000372_irregular_coat_pigmentation | 0.74286468 |
| 121 | MP0004381_abnormal_hair_follicle | 0.73513511 |
| 122 | MP0003724_increased_susceptibility_to | 0.73416348 |
| 123 | MP0001177_atelectasis | 0.73228251 |
| 124 | MP0000747_muscle_weakness | 0.72646291 |
| 125 | MP0003172_abnormal_lysosome_physiology | 0.72136834 |
| 126 | MP0003879_abnormal_hair_cell | 0.71922310 |
| 127 | MP0005645_abnormal_hypothalamus_physiol | 0.71835644 |
| 128 | MP0003890_abnormal_embryonic-extraembry | 0.70829050 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.69863911 |
| 130 | MP0002928_abnormal_bile_duct | 0.69542545 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.68832568 |
| 132 | MP0000538_abnormal_urinary_bladder | 0.68559329 |
| 133 | MP0001324_abnormal_eye_pigmentation | 0.68423978 |
| 134 | MP0000049_abnormal_middle_ear | 0.68212997 |
| 135 | MP0005000_abnormal_immune_tolerance | 0.67766520 |
| 136 | MP0006035_abnormal_mitochondrial_morpho | 0.67536975 |
| 137 | MP0001299_abnormal_eye_distance/ | 0.66518744 |
| 138 | MP0005623_abnormal_meninges_morphology | 0.65135893 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.62573198 |
| 140 | MP0008789_abnormal_olfactory_epithelium | 0.61841783 |
| 141 | * MP0002152_abnormal_brain_morphology | 0.60517288 |
| 142 | MP0001943_abnormal_respiration | 0.59910038 |
| 143 | MP0000013_abnormal_adipose_tissue | 0.58541899 |
| 144 | MP0005410_abnormal_fertilization | 0.57391971 |
| 145 | MP0004085_abnormal_heartbeat | 0.55718236 |
| 146 | MP0004215_abnormal_myocardial_fiber | 0.55494088 |
| 147 | MP0001963_abnormal_hearing_physiology | 0.51000642 |
| 148 | MP0004145_abnormal_muscle_electrophysio | 0.50471831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 6.01177951 |
| 2 | Pheochromocytoma (HP:0002666) | 5.83640266 |
| 3 | Visual hallucinations (HP:0002367) | 5.44045453 |
| 4 | Neuroendocrine neoplasm (HP:0100634) | 5.18894981 |
| 5 | Facial shape deformation (HP:0011334) | 4.66177594 |
| 6 | Potter facies (HP:0002009) | 4.66177594 |
| 7 | 3-Methylglutaconic aciduria (HP:0003535) | 4.36214522 |
| 8 | Focal seizures (HP:0007359) | 4.21181334 |
| 9 | Failure to thrive in infancy (HP:0001531) | 4.20028809 |
| 10 | Central scotoma (HP:0000603) | 4.17918471 |
| 11 | Decreased central vision (HP:0007663) | 3.90676588 |
| 12 | Focal motor seizures (HP:0011153) | 3.85247038 |
| 13 | Hypokinesia (HP:0002375) | 3.80520937 |
| 14 | Abnormality of macular pigmentation (HP:0008002) | 3.77781847 |
| 15 | Hypothermia (HP:0002045) | 3.66092130 |
| 16 | Oligodactyly (hands) (HP:0001180) | 3.54205422 |
| 17 | Myokymia (HP:0002411) | 3.48040456 |
| 18 | Birth length less than 3rd percentile (HP:0003561) | 3.41348832 |
| 19 | Abnormal pupillary function (HP:0007686) | 3.38332366 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.32794663 |
| 21 | Global brain atrophy (HP:0002283) | 3.31656798 |
| 22 | Lipid accumulation in hepatocytes (HP:0006561) | 3.30945722 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 3.29865102 |
| 24 | Abnormality of midbrain morphology (HP:0002418) | 3.29865102 |
| 25 | Hypoventilation (HP:0002791) | 3.28759604 |
| 26 | Abnormality of the parathyroid morphology (HP:0011766) | 3.27718089 |
| 27 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.25926696 |
| 28 | Delayed gross motor development (HP:0002194) | 3.20694909 |
| 29 | Atonic seizures (HP:0010819) | 3.15140556 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.14224682 |
| 31 | Absence seizures (HP:0002121) | 3.12165439 |
| 32 | Dialeptic seizures (HP:0011146) | 3.10572160 |
| 33 | Scotoma (HP:0000575) | 3.07049271 |
| 34 | Gait imbalance (HP:0002141) | 3.01978709 |
| 35 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.98019164 |
| 36 | Long nose (HP:0003189) | 2.97996957 |
| 37 | Pancreatic cysts (HP:0001737) | 2.97696963 |
| 38 | Epileptic encephalopathy (HP:0200134) | 2.96372313 |
| 39 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.96183217 |
| 40 | Growth hormone deficiency (HP:0000824) | 2.94924081 |
| 41 | Generalized tonic-clonic seizures (HP:0002069) | 2.94722833 |
| 42 | Increased hepatocellular lipid droplets (HP:0006565) | 2.94231310 |
| 43 | Pancreatic fibrosis (HP:0100732) | 2.92617820 |
| 44 | Cerebral hemorrhage (HP:0001342) | 2.88118600 |
| 45 | Congenital, generalized hypertrichosis (HP:0004540) | 2.85750197 |
| 46 | Tubular atrophy (HP:0000092) | 2.85730524 |
| 47 | Abnormal number of erythroid precursors (HP:0012131) | 2.84580928 |
| 48 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.83371782 |
| 49 | Nephronophthisis (HP:0000090) | 2.83100538 |
| 50 | Febrile seizures (HP:0002373) | 2.82190130 |
| 51 | Diminished movement (HP:0002374) | 2.81675071 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.78819187 |
| 53 | Hepatocellular necrosis (HP:0001404) | 2.78526141 |
| 54 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.77218299 |
| 55 | Increased corneal curvature (HP:0100692) | 2.77129263 |
| 56 | Keratoconus (HP:0000563) | 2.77129263 |
| 57 | Abnormality of the 4th metacarpal (HP:0010012) | 2.73306885 |
| 58 | Hypercortisolism (HP:0001578) | 2.73076878 |
| 59 | Muscular hypotonia of the trunk (HP:0008936) | 2.71138654 |
| 60 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.68453257 |
| 61 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.66107480 |
| 62 | Medial flaring of the eyebrow (HP:0010747) | 2.65278162 |
| 63 | Concave nail (HP:0001598) | 2.65052093 |
| 64 | Rib fusion (HP:0000902) | 2.64456881 |
| 65 | Severe visual impairment (HP:0001141) | 2.62617815 |
| 66 | Inability to walk (HP:0002540) | 2.61637487 |
| 67 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.61381616 |
| 68 | Acute necrotizing encephalopathy (HP:0006965) | 2.59810148 |
| 69 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.59661579 |
| 70 | Abnormal ciliary motility (HP:0012262) | 2.58782723 |
| 71 | Protruding tongue (HP:0010808) | 2.58561603 |
| 72 | Cone-rod dystrophy (HP:0000548) | 2.57217487 |
| 73 | Dysautonomia (HP:0002459) | 2.54149328 |
| 74 | Truncal ataxia (HP:0002078) | 2.53653240 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.53651652 |
| 76 | Cholecystitis (HP:0001082) | 2.53651652 |
| 77 | Hypoplasia of the pons (HP:0012110) | 2.52445200 |
| 78 | Rigidity (HP:0002063) | 2.52356717 |
| 79 | Oligodactyly (HP:0012165) | 2.52319911 |
| 80 | Abnormality of the renal cortex (HP:0011035) | 2.49428043 |
| 81 | Renal cortical cysts (HP:0000803) | 2.49417312 |
| 82 | Hypogonadotrophic hypogonadism (HP:0000044) | 2.49204832 |
| 83 | Congenital primary aphakia (HP:0007707) | 2.44459096 |
| 84 | Genital tract atresia (HP:0001827) | 2.41834893 |
| 85 | Vaginal atresia (HP:0000148) | 2.41514897 |
| 86 | Hyperventilation (HP:0002883) | 2.40970326 |
| 87 | Anophthalmia (HP:0000528) | 2.38582080 |
| 88 | Mesangial abnormality (HP:0001966) | 2.38191490 |
| 89 | Postural tremor (HP:0002174) | 2.37997317 |
| 90 | Hepatic necrosis (HP:0002605) | 2.36292909 |
| 91 | True hermaphroditism (HP:0010459) | 2.35621240 |
| 92 | Retinal dysplasia (HP:0007973) | 2.35571157 |
| 93 | Abnormality of the pons (HP:0007361) | 2.29397434 |
| 94 | Increased CSF lactate (HP:0002490) | 2.28498973 |
| 95 | Nephrogenic diabetes insipidus (HP:0009806) | 2.27721876 |
| 96 | Limb hypertonia (HP:0002509) | 2.26237605 |
| 97 | Progressive macrocephaly (HP:0004481) | 2.26173528 |
| 98 | Choroideremia (HP:0001139) | 2.23776887 |
| 99 | Microvesicular hepatic steatosis (HP:0001414) | 2.22426997 |
| 100 | Spastic tetraparesis (HP:0001285) | 2.20020019 |
| 101 | Optic disc pallor (HP:0000543) | 2.19387009 |
| 102 | Absent/shortened dynein arms (HP:0200106) | 2.18953454 |
| 103 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.18953454 |
| 104 | Ankle clonus (HP:0011448) | 2.18137016 |
| 105 | Anterior segment dysgenesis (HP:0007700) | 2.16414069 |
| 106 | Bradykinesia (HP:0002067) | 2.16156606 |
| 107 | Abnormal biliary tract physiology (HP:0012439) | 2.16123962 |
| 108 | Bile duct proliferation (HP:0001408) | 2.16123962 |
| 109 | Abolished electroretinogram (ERG) (HP:0000550) | 2.16109755 |
| 110 | Chronic hepatic failure (HP:0100626) | 2.15128869 |
| 111 | Spastic gait (HP:0002064) | 2.13295003 |
| 112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13087123 |
| 113 | Abnormality of the renal medulla (HP:0100957) | 2.12699988 |
| 114 | Type II lissencephaly (HP:0007260) | 2.12201859 |
| 115 | Mitochondrial inheritance (HP:0001427) | 2.11290600 |
| 116 | Hypoalbuminemia (HP:0003073) | 2.09425675 |
| 117 | Abnormal albumin level (HP:0012116) | 2.09425675 |
| 118 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.07089628 |
| 119 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.06465020 |
| 120 | Delusions (HP:0000746) | 2.05572253 |
| 121 | Anxiety (HP:0000739) | 2.04515564 |
| 122 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.04495408 |
| 123 | Renal Fanconi syndrome (HP:0001994) | 2.03694024 |
| 124 | Depression (HP:0000716) | 2.02815517 |
| 125 | Pendular nystagmus (HP:0012043) | 2.02463106 |
| 126 | Supranuclear gaze palsy (HP:0000605) | 2.01102919 |
| 127 | Diplopia (HP:0000651) | 2.00946584 |
| 128 | Abnormality of binocular vision (HP:0011514) | 2.00946584 |
| 129 | Chorioretinal atrophy (HP:0000533) | 2.00857755 |
| 130 | Encephalitis (HP:0002383) | 2.00697128 |
| 131 | Limb dystonia (HP:0002451) | 10.4939182 |
| 132 | Anencephaly (HP:0002323) | 1.99422857 |
| 133 | Exertional dyspnea (HP:0002875) | 1.99167938 |
| 134 | Flat occiput (HP:0005469) | 1.98614935 |
| 135 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.96920155 |
| 136 | Erectile abnormalities (HP:0100639) | 1.95801219 |
| 137 | Intellectual disability, progressive (HP:0006887) | 1.95682530 |
| 138 | Disproportionate short-trunk short stature (HP:0003521) | 1.95590284 |
| 139 | Insidious onset (HP:0003587) | 1.95515541 |
| 140 | Termporal pattern (HP:0011008) | 1.95515541 |
| 141 | Polyphagia (HP:0002591) | 1.95161647 |
| 142 | Clumsiness (HP:0002312) | 1.95096767 |
| 143 | Neoplasm of the heart (HP:0100544) | 1.94996082 |
| 144 | Abnormality of pain sensation (HP:0010832) | 1.94813367 |
| 145 | Impaired pain sensation (HP:0007328) | 1.94813367 |
| 146 | Myoclonus (HP:0001336) | 1.94775980 |
| 147 | Septo-optic dysplasia (HP:0100842) | 1.94651111 |
| 148 | Reticulocytopenia (HP:0001896) | 1.94382999 |
| 149 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93584955 |
| 150 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.93295507 |
| 151 | Abnormality of alanine metabolism (HP:0010916) | 1.93295507 |
| 152 | Hyperalaninemia (HP:0003348) | 1.93295507 |
| 153 | Partial agenesis of the corpus callosum (HP:0001338) | 1.93252274 |
| 154 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92986947 |
| 155 | Progressive inability to walk (HP:0002505) | 1.92887382 |
| 156 | Dyskinesia (HP:0100660) | 1.92663153 |
| 157 | Acute encephalopathy (HP:0006846) | 1.91206335 |
| 158 | Epileptiform EEG discharges (HP:0011182) | 1.88117633 |
| 159 | B lymphocytopenia (HP:0010976) | 1.87682086 |
| 160 | Abnormal eating behavior (HP:0100738) | 1.86856026 |
| 161 | Abnormality of B cell number (HP:0010975) | 1.85972965 |
| 162 | Parakeratosis (HP:0001036) | 1.85650172 |
| 163 | Urinary urgency (HP:0000012) | 1.85221744 |
| 164 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83187138 |
| 165 | Dyschromatopsia (HP:0007641) | 1.81105011 |
| 166 | Macular degeneration (HP:0000608) | 1.80477317 |
| 167 | Sclerocornea (HP:0000647) | 1.80408202 |
| 168 | Fibular hypoplasia (HP:0003038) | 1.79454258 |
| 169 | Mask-like facies (HP:0000298) | 1.79277629 |
| 170 | Increased muscle lipid content (HP:0009058) | 1.79087368 |
| 171 | Thyroid carcinoma (HP:0002890) | 1.78303341 |
| 172 | Cystic liver disease (HP:0006706) | 1.77996947 |
| 173 | Abnormal hair whorl (HP:0010721) | 1.77895759 |
| 174 | Poor suck (HP:0002033) | 1.77186158 |
| 175 | Abnormality of glycolysis (HP:0004366) | 1.76322223 |
| 176 | Esophageal atresia (HP:0002032) | 1.75991005 |
| 177 | Congenital hepatic fibrosis (HP:0002612) | 1.75449901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 4.59670288 |
| 2 | MAPKAPK5 | 4.09671615 |
| 3 | MAP3K12 | 3.85885417 |
| 4 | GRK5 | 3.59101470 |
| 5 | TLK1 | 3.48992983 |
| 6 | WNK3 | 3.22237727 |
| 7 | MARK1 | 2.94533380 |
| 8 | CSNK1G3 | 2.73637071 |
| 9 | MINK1 | 2.62311793 |
| 10 | NEK1 | 2.57404222 |
| 11 | MAP3K9 | 2.49430406 |
| 12 | BCKDK | 2.48242320 |
| 13 | CSNK1G2 | 2.39136724 |
| 14 | PLK2 | 2.33223024 |
| 15 | MAP3K4 | 2.21815901 |
| 16 | DYRK2 | 2.02858285 |
| 17 | PNCK | 1.99177412 |
| 18 | MAP2K4 | 1.97675971 |
| 19 | NTRK1 | 1.89079700 |
| 20 | CSNK1G1 | 1.87415355 |
| 21 | TAOK3 | 1.86965215 |
| 22 | GRK6 | 1.85041663 |
| 23 | MAP2K7 | 1.84863855 |
| 24 | ZAK | 1.78607317 |
| 25 | BMPR1B | 1.71800202 |
| 26 | MKNK1 | 1.69185715 |
| 27 | CDK14 | 1.69153415 |
| 28 | KSR2 | 1.67729963 |
| 29 | RET | 1.63096329 |
| 30 | PHKG1 | 1.58938853 |
| 31 | PHKG2 | 1.58938853 |
| 32 | FES | 1.55674687 |
| 33 | INSRR | 1.54157511 |
| 34 | CDK15 | 1.53846708 |
| 35 | CDK18 | 1.53719306 |
| 36 | NEK2 | 1.53296823 |
| 37 | TYRO3 | 1.52662700 |
| 38 | NTRK3 | 1.48364093 |
| 39 | FGR | 1.48068633 |
| 40 | TXK | 1.47827253 |
| 41 | CASK | 1.45326793 |
| 42 | ARAF | 1.43496460 |
| 43 | CAMK2A | 1.42879944 |
| 44 | RIPK4 | 1.40586337 |
| 45 | CDK11A | 1.40479216 |
| 46 | CAMK2D | 1.38663626 |
| 47 | LMTK2 | 1.37107368 |
| 48 | STK38L | 1.37089432 |
| 49 | ADRBK2 | 1.37053122 |
| 50 | CDK5 | 1.30018462 |
| 51 | DYRK1A | 1.26875404 |
| 52 | DAPK2 | 1.26055420 |
| 53 | LATS2 | 1.25050685 |
| 54 | LIMK1 | 1.23591446 |
| 55 | STK39 | 1.23542628 |
| 56 | SIK2 | 1.22873654 |
| 57 | EPHA4 | 1.20392298 |
| 58 | WNK4 | 1.18648508 |
| 59 | GRK7 | 1.18641055 |
| 60 | PAK6 | 1.17830687 |
| 61 | ADRBK1 | 1.15850727 |
| 62 | PTK2B | 1.12751482 |
| 63 | PRKCQ | 1.12678865 |
| 64 | SYK | 1.12319707 |
| 65 | FER | 1.11549323 |
| 66 | STK38 | 1.10682465 |
| 67 | WEE1 | 1.07968732 |
| 68 | PLK4 | 1.02883314 |
| 69 | CAMK2B | 1.00997123 |
| 70 | MAPKAPK3 | 1.00730670 |
| 71 | GRK1 | 0.95121795 |
| 72 | MKNK2 | 0.94267988 |
| 73 | WNK1 | 0.92874656 |
| 74 | TNIK | 0.92620938 |
| 75 | NEK9 | 0.92075375 |
| 76 | PIK3CG | 0.90325033 |
| 77 | CHEK2 | 0.89631999 |
| 78 | SGK494 | 0.88204237 |
| 79 | SGK223 | 0.88204237 |
| 80 | PRKCG | 0.86676837 |
| 81 | EPHA3 | 0.82798648 |
| 82 | UHMK1 | 0.80984407 |
| 83 | TSSK6 | 0.78293910 |
| 84 | PTK2 | 0.77869536 |
| 85 | VRK1 | 0.77225134 |
| 86 | CAMK2G | 0.76947369 |
| 87 | TGFBR1 | 0.76324762 |
| 88 | EPHB2 | 0.73958213 |
| 89 | PLK3 | 0.72450981 |
| 90 | PAK3 | 0.71734443 |
| 91 | NTRK2 | 0.70346265 |
| 92 | SIK3 | 0.70155289 |
| 93 | PIK3CA | 0.69779860 |
| 94 | ROCK2 | 0.69070368 |
| 95 | MAP3K2 | 0.68226018 |
| 96 | MAP4K1 | 0.67344982 |
| 97 | MATK | 0.66754065 |
| 98 | KIT | 0.66415921 |
| 99 | BLK | 0.65893433 |
| 100 | KSR1 | 0.65603220 |
| 101 | MAPK13 | 0.65003504 |
| 102 | NME1 | 0.64757384 |
| 103 | MAPK4 | 0.64407235 |
| 104 | ACVR1B | 0.61856519 |
| 105 | ITK | 0.61366909 |
| 106 | ERBB3 | 0.59579710 |
| 107 | CAMK1G | 0.57285937 |
| 108 | MAPK15 | 0.57221748 |
| 109 | LYN | 0.55069609 |
| 110 | RPS6KA5 | 0.53225772 |
| 111 | BCR | 0.52981497 |
| 112 | CAMKK1 | 0.52804966 |
| 113 | PINK1 | 0.52292094 |
| 114 | RIPK1 | 0.51246634 |
| 115 | MYLK | 0.50752209 |
| 116 | TEC | 0.50585939 |
| 117 | IKBKE | 0.50218960 |
| 118 | MAP3K11 | 0.49824853 |
| 119 | PRKCE | 0.48534856 |
| 120 | IKBKB | 0.48295786 |
| 121 | MARK3 | 0.47534725 |
| 122 | SCYL2 | 0.47313261 |
| 123 | MAPK10 | 0.46929181 |
| 124 | PKN1 | 0.46330366 |
| 125 | PRKCB | 0.45360174 |
| 126 | CHUK | 0.45201832 |
| 127 | PRKCZ | 0.44127045 |
| 128 | PRKCA | 0.43373893 |
| 129 | AKT3 | 0.42618741 |
| 130 | CDC42BPA | 0.41256798 |
| 131 | KDR | 0.40237230 |
| 132 | BTK | 0.40190748 |
| 133 | PRKACA | 0.40101980 |
| 134 | FYN | 0.40081476 |
| 135 | MAP2K1 | 0.39902379 |
| 136 | MAP3K1 | 0.39529208 |
| 137 | PRKCI | 0.38352962 |
| 138 | TRPM7 | 0.38022246 |
| 139 | PRKAA1 | 0.36660777 |
| 140 | CSNK1E | 0.35530590 |
| 141 | MAP3K13 | 0.34029079 |
| 142 | MAPK3 | 0.33880380 |
| 143 | STK16 | 0.33552189 |
| 144 | PRKG1 | 0.33077110 |
| 145 | CSNK1D | 0.32154619 |
| 146 | TYK2 | 0.32114345 |
| 147 | RPS6KA3 | 0.31883154 |
| 148 | MAPK12 | 0.31681018 |
| 149 | SGK2 | 0.30312098 |
| 150 | CSNK1A1 | 0.29687269 |
| 151 | DAPK3 | 0.29515664 |
| 152 | ERBB4 | 0.29072950 |
| 153 | CDK19 | 0.28623022 |
| 154 | VRK2 | 0.28319410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 5.77436558 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 5.24028498 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.86812114 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.38276895 |
| 5 | Cocaine addiction_Homo sapiens_hsa05030 | 3.25940817 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 3.11844866 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.93871259 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.76913980 |
| 9 | * Nicotine addiction_Homo sapiens_hsa05033 | 2.63837522 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.61469446 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.55761120 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.53028181 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.50551518 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.47416651 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.30863956 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.29887224 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.09773247 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.06516233 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 2.03906881 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 2.01647766 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.99770144 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.88385000 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.82217439 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.79943082 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.79559308 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77452747 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.75217835 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.73097561 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.63566325 |
| 30 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.62874234 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.61363254 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.60324181 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.57366229 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.56800680 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52821196 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.52355801 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.48296993 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45946424 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.45497193 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.42018837 |
| 41 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.40982001 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39389108 |
| 43 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35750799 |
| 44 | RNA polymerase_Homo sapiens_hsa03020 | 1.30294801 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.27234134 |
| 46 | Long-term depression_Homo sapiens_hsa04730 | 1.26930203 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23152414 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 1.22771714 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 1.22394556 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19488676 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18623507 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17648075 |
| 53 | Gap junction_Homo sapiens_hsa04540 | 1.17150872 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16971746 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16518741 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.16019439 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14943272 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13251097 |
| 59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.10647751 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09999565 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09837421 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06690635 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03114148 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02153776 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00942333 |
| 66 | Alcoholism_Homo sapiens_hsa05034 | 0.97611059 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96083225 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.95541783 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95051372 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94699006 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94315817 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89916121 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89258848 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88903776 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.85224201 |
| 76 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82719373 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80250576 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79994292 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79069868 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78519766 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77101094 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76685819 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75103498 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71961480 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.69524666 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69433617 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68730842 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68160335 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.67977313 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67839094 |
| 91 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66804653 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66190421 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65761648 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65120471 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64027897 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62784375 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.61186487 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.60531453 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60378602 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60171847 |
| 101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58815304 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58505628 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58252515 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.54755063 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52473171 |
| 106 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51938058 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.51877071 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50430524 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49871329 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49082416 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48310168 |
| 112 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46877499 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44901593 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44055696 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43947962 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43242759 |
| 117 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43025098 |
| 118 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42605001 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40918566 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39742723 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39596631 |
| 122 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39500530 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38348544 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38223445 |
| 125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37844005 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37785758 |
| 127 | Peroxisome_Homo sapiens_hsa04146 | 0.37382401 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37362919 |
| 129 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36786199 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36754501 |
| 131 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36023374 |
| 132 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35097106 |
| 133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33308356 |
| 134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32426241 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28294970 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.27772542 |
| 137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.27023331 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.25406748 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24611649 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24195371 |
| 141 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.23749697 |
| 142 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.22754440 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22144011 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21458720 |
| 145 | Purine metabolism_Homo sapiens_hsa00230 | 0.21236755 |
| 146 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.20312519 |
| 147 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.20188612 |
| 148 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20042310 |
| 149 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.19864417 |
| 150 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19787241 |
| 151 | Proteasome_Homo sapiens_hsa03050 | 0.19635554 |
| 152 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.19503168 |
| 153 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.19426926 |
| 154 | Retinol metabolism_Homo sapiens_hsa00830 | 0.19084644 |
| 155 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.17190099 |
| 156 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15494588 |
| 157 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.15446991 |
| 158 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14875375 |
| 159 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.14523077 |
| 160 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13658138 |

